This excerpt taken from the GENZ 10-Q filed Nov 7, 2008.
PART II. OTHER INFORMATION
We periodically become subject to legal proceedings and claims arising in connection with our business. Although we cannot predict the outcome of these additional proceedings and claims, we do not believe the ultimate resolution of any of these existing matters would have a material adverse effect on our consolidated financial position or results of operations.
We incorporate by reference our disclosure related to risk factors which is set forth under the heading "Management's Discussion and Analysis of Financial Condition and Results of OperationsRisk Factors" in Part I., Item 2. of this Quarterly Report on Form 10-Q.
The following table provides information about our repurchases of our equity securities during the quarter ended September 30, 2008:
See the Exhibit Index following the signature page to this report on Form 10-Q.
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
GENZYME CORPORATION AND SUBSIDIARIES